Lanlan Pang
Impact in
-
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
- Ferroptosis and cancer prognosis
Papers in
- Oncology 20
- Colorectal Cancer Treatments and Studies 6
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 3
-
- Lung Cancer Treatments and Mutations 12
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Chongxiang Chen (5 shared papers)Yihua Huang (10 shared papers)Jiadi Gan (7 shared papers)Wenfeng Fang (10 shared papers)Wei Liao (2 shared papers)Yanyan Wang (2 shared papers)Huan Li (2 shared papers)Weitao Zhuang (8 shared papers)
- Journals
- Lung Cancer (3 papers)Journal of Thoracic Oncology (2 papers)Therapeutic Advances in Chronic Disease (2 papers)Annals of Translational Medicine (2 papers)Neoplasia (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Lanlan Pang
28 papers receiving 279 citations
Peers
Comparison fields: 5 of 61
- Oncology 97
- Pulmonary and Respiratory Medicine 106
- Endocrine and Autonomic Systems 16
- Cancer Research 31
- Health Informatics 2
Countries citing papers authored by Lanlan Pang
This map shows the geographic impact of Lanlan Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Pang more than expected).
Fields of papers citing papers by Lanlan Pang
This network shows the impact of papers produced by Lanlan Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Pang. The network helps show where Lanlan Pang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanlan Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 38 | |
| 2 | 2021 | 36 | |
| 3 | 2020 | 28 | |
| 4 | 2020 | 25 | |
| 5 | 2024 | 23 | |
| 6 | 2020 | 21 | |
| 7 | 2022 | 13 | |
| 8 | 2021 | 12 | |
| 9 | 2022 | 12 | |
| 10 | 2023 | 10 | |
| 11 | 2023 | 10 | |
| 12 | 2019 | 8 | |
| 13 | 2000 | 7 | |
| 14 | 2024 | 7 | |
| 15 | 2024 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2017 | 3 |
About Lanlan Pang
Lanlan Pang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Pathology and Forensic Medicine, having authored 31 papers that have together received 282 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Colorectal Cancer Treatments and Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Chromatin Remodeling and Cancer (3 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Oncology (97 citations), Pulmonary and Respiratory Medicine (106 citations), Endocrine and Autonomic Systems (16 citations), Cancer Research (31 citations) and Health Informatics (2 citations). Lanlan Pang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Chongxiang Chen, Yihua Huang, Jiadi Gan, Wenfeng Fang, Wei Liao, Yanyan Wang, Huan Li, Weitao Zhuang, Gang Ma and Jiaojiao Wang. Their work appears in journals such as Lung Cancer, Journal of Thoracic Oncology, Therapeutic Advances in Chronic Disease, Annals of Translational Medicine and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.